84 related articles for article (PubMed ID: 26250644)
1. A Novel Selective PPARα Modulator.
Doi T
J Atheroscler Thromb; 2015 Aug; 22(8):750-1. PubMed ID: 26250644
[No Abstract] [Full Text] [Related]
2. Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.
Raza-Iqbal S; Tanaka T; Anai M; Inagaki T; Matsumura Y; Ikeda K; Taguchi A; Gonzalez FJ; Sakai J; Kodama T
J Atheroscler Thromb; 2015 Aug; 22(8):754-72. PubMed ID: 26040752
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression Profiles Induced by a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα) Pemafibrate.
Sasaki Y; Raza-Iqbal S; Tanaka T; Murakami K; Anai M; Osawa T; Matsumura Y; Sakai J; Kodama T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766193
[TBL] [Abstract][Full Text] [Related]
4. Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice.
Takei K; Nakagawa Y; Wang Y; Han SI; Satoh A; Sekiya M; Matsuzaka T; Shimano H
J Pharmacol Sci; 2017 Apr; 133(4):214-222. PubMed ID: 28366492
[TBL] [Abstract][Full Text] [Related]
5. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
[TBL] [Abstract][Full Text] [Related]
6. Selective PPARα agonist pemafibrate inhibits TNF-α-induced S100A7 upregulation in keratinocytes.
Yumine A; Tsuji G; Furue M
J Dermatol Sci; 2020 Jul; 99(1):69-72. PubMed ID: 32507539
[No Abstract] [Full Text] [Related]
7. Renoprotective effect of a novel selective PPARα modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway.
Maki T; Maeda Y; Sonoda N; Makimura H; Kimura S; Maeno S; Takayanagi R; Inoguchi T
Metabolism; 2017 Jun; 71():33-45. PubMed ID: 28521876
[TBL] [Abstract][Full Text] [Related]
8. Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis.
Honda Y; Kessoku T; Ogawa Y; Tomeno W; Imajo K; Fujita K; Yoneda M; Takizawa T; Saito S; Nagashima Y; Nakajima A
Sci Rep; 2017 Feb; 7():42477. PubMed ID: 28195199
[TBL] [Abstract][Full Text] [Related]
9. The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice.
Araki M; Nakagawa Y; Oishi A; Han SI; Wang Y; Kumagai K; Ohno H; Mizunoe Y; Iwasaki H; Sekiya M; Matsuzaka T; Shimano H
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041488
[TBL] [Abstract][Full Text] [Related]
10. Pemafibrate: First Global Approval.
Blair HA
Drugs; 2017 Oct; 77(16):1805-1810. PubMed ID: 28929345
[TBL] [Abstract][Full Text] [Related]
11. Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα.
Yamamoto Y; Takei K; Arulmozhiraja S; Sladek V; Matsuo N; Han SI; Matsuzaka T; Sekiya M; Tokiwa T; Shoji M; Shigeta Y; Nakagawa Y; Tokiwa H; Shimano H
Biochem Biophys Res Commun; 2018 May; 499(2):239-245. PubMed ID: 29567478
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
Szalowska E; Tesfay HA; van Hijum SA; Kersten S
BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
[TBL] [Abstract][Full Text] [Related]
13. Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver.
Yamada T; Okuda Y; Kushida M; Sumida K; Takeuchi H; Nagahori H; Fukuda T; Lake BG; Cohen SM; Kawamura S
Toxicol Sci; 2014 Nov; 142(1):137-57. PubMed ID: 25145657
[TBL] [Abstract][Full Text] [Related]
14. Exploring Chronic Drug Effects on Microengineered Human Liver Cultures Using Global Gene Expression Profiling.
Ware BR; McVay M; Sunada WY; Khetani SR
Toxicol Sci; 2017 Jun; 157(2):387-398. PubMed ID: 28369597
[TBL] [Abstract][Full Text] [Related]
15. Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial.
Ishibashi S; Yamashita S; Arai H; Araki E; Yokote K; Suganami H; Fruchart JC; Kodama T;
Atherosclerosis; 2016 Jun; 249():36-43. PubMed ID: 27062408
[TBL] [Abstract][Full Text] [Related]
16. Protective action of schizandrin B on hepatic injury in mice.
Pao TT; Hsu KF; Liu KT; Chang LG; Chuang CH; Sung CY
Chin Med J (Engl); 1977 May; 3(3):173-9. PubMed ID: 410602
[No Abstract] [Full Text] [Related]
17. In vitro differentiation of hepatic progenitor cells from mouse embryonic stem cells induced by sodium butyrate.
Zhou QJ; Xiang LX; Shao JZ; Hu RZ; Lu YL; Yao H; Dai LC
J Cell Biochem; 2007 Jan; 100(1):29-42. PubMed ID: 16888815
[TBL] [Abstract][Full Text] [Related]
18. Efficient derivation of functional hepatocytes from mouse induced pluripotent stem cells by a combination of cytokines and sodium butyrate.
Zhang Q; Yang Y; Zhang J; Wang GY; Liu W; Qiu DB; Hei ZQ; Ying QL; Chen GH
Chin Med J (Engl); 2011 Nov; 124(22):3786-93. PubMed ID: 22340242
[TBL] [Abstract][Full Text] [Related]
19. Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes.
Kandel BA; Thomas M; Winter S; Damm G; Seehofer D; Burk O; Schwab M; Zanger UM
Biochim Biophys Acta; 2016 Sep; 1859(9):1218-1227. PubMed ID: 26994748
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models.
Doktorova TY; Yildirimman R; Vinken M; Vilardell M; Vanhaecke T; Gmuender H; Bort R; Brolen G; Holmgren G; Li R; Chesne C; van Delft J; Kleinjans J; Castell J; Bjorquist P; Herwig R; Rogiers V
Carcinogenesis; 2013 Jun; 34(6):1393-402. PubMed ID: 23393228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
